Assuta Medical Center
| Izrael | Turcja | Austria | |
| Terapia mikroprądami | - | od $750 | - |
| Terapia komórkami macierzystymi przy przewlekłym bólu | - | od $6,500 | od $13,000 |
| Stymulator rdzenia kręgowego (SCS) | - | od $16,000 | od $32,000 |
Dr Chernuha specjalizuje się w neurologii dziecięcej oraz posiada zaawansowane przeszkolenie w zakresie epilepsji lekoopornej. Leczy dzieci w Centrum Medycznym Sourasky.
Posiadając ponad 30-letnie doświadczenie, dr Gurevich kieruje zespołem leczącym chorobę Parkinsona w Centrum Medycznym Sourasky w Tel Awiwie.
Dyrektor Oddziału Neurologii Dziecięcej w Centrum Medycznym Sourasky – Aviva Fattal-Valevski specjalizuje się w chorobach neurogenetycznych mózgu u dzieci.
Prof. Nir Giladi to jeden z czołowych izraelskich neurologów z ponad 30-letnim doświadczeniem. Specjalizuje się w chorobie Parkinsona i współpracuje z Fundacją Michaela J. Foxa.
Chronic pain centers in Israel primarily treat lower back pain (36%), migraines (21%), and neck pain (14%). Therapeutic options include advanced neuromodulation, medical cannabis, and regenerative medicine. Facilities like Sourasky Medical Center and Assuta Medical Center provide multidisciplinary care via JCI-accredited protocols and specialized rehabilitation.
Bookimed Expert Insight: Israeli pain management stands out because of the high concentration of neurological expertise in Tel Aviv. At Sourasky Medical Center alone, over 2,200 doctors operate across 240 departments. This density allows for immediate cross-consultation between pain specialists and neurosurgeons. Patients with complex conditions like Parkinson-related pain or treatment-resistant migraines benefit from this integrated approach, which often includes innovative protocols developed by the clinic's own researchers.
Patient Consensus: Patients note that private clinics offer much faster access to advanced treatments like ozone therapy or IV ketamine infusions for fibromyalgia. Many highlight that medical cannabis is frequently used as an effective first-line therapy for neuropathy without the risks associated with other medications.
Implantable devices are highly safe in Israel due to strict Ministry of Health oversight and adherence to United States FDA and European CE standards. Leading centers minimize complications through mandatory trial periods and rigorous patient selection. Specialized surgeons utilize minimally invasive percutaneous techniques to ensure long-term device stability.
Bookimed Expert Insight: Israeli medical centers demonstrate a high level of surgical precision by performing massive patient volumes. For example, Assuta Medical Center conducts 92,000 operations annually, while Sourasky Medical Center serves 1,800,000 patients. This extreme procedural density allows specialized units to refine implantation techniques, which is key to keeping device-related complication rates low.
Patient Consensus: Patients emphasize that an extended trial period of at least 2 weeks is vital to avoid future regrets. They also note that choosing high-volume centers helps ensure surgeons are experienced in handling potential lead migration issues.
Qualified Israeli pain specialists must hold a primary certification in Anesthesiology, Neurosurgery, or Neurology. They must complete a 27 month Pain Medicine subspecialty recognized by the Israel Medical Association. Look for experts practicing at JCI-accredited facilities like Sourasky Medical Center or Assuta Medical Center.
Bookimed Expert Insight: Data from major hubs like Sourasky Medical Center shows a trend toward multidisciplinary teams. While a surgeon performs the implant, clinics with over 2,000 doctors often include dedicated neurologists for post-operative programming. This collaborative approach significantly improves long-term pain management results compared to solo practices.
Patient Consensus: Patients emphasize choosing physicians who perform fluoroscopy-guided procedures daily to ensure precision. They also recommend verifying if a specialist has completed fellowships at recognized international institutions like the Mayo Clinic.
For a spinal cord stimulator in Israel, plan a stay of 10 to 14 days for a single-stage trial. If combining the trial and permanent implant, the trip extends to 3 to 4 weeks. This timeframe ensures proper lead placement, healing, and initial device programming.
Bookimed Expert Insight: Israeli medical centers like Sourasky or Assuta often process the highest patient volumes in the region. Our data suggests choosing a center with specialized rehabilitation departments, like Loewenstein, if your chronic pain requires intensive post-op adjustment. This integrated approach can reduce the 30% revision rate sometimes seen when programming is rushed for travel.
Patient Consensus: Patients emphasize packing for potential stay extensions and securing travel insurance. They note that staying at least 3 weeks prevents issues with remote device programming once back home.
Radiofrequency ablation of medial branches or the dorsal root ganglion is generally safe. Common side effects include temporary localized soreness or a sunburn sensation lasting up to 2 weeks. Rare risks include neuritis or nerve injury. Specialists mitigate these using live fluoroscopy and sensory testing.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center and Assuta handle massive patient volumes, performing between 34,000 and 92,000 operations annually. This high procedural frequency often correlates with refined safety protocols. For complex dorsal root ganglion procedures, choosing these high-volume, JCI-accredited facilities ensures access to multidisciplinary teams. These teams include senior neurologists and professors who specialize in identifying rare contraindications before the procedure begins.
Patient Consensus: Patients emphasize the importance of having at least 2 successful diagnostic blocks before proceeding with the full ablation. Many note that preparing for 2 weeks of downtime with ice packs helps manage the initial increase in discomfort.
Hebrew-only documentation remains a manageable hurdle for foreigners seeking chronic pain treatment in Israel. While primary medical records are in Hebrew, JCI-accredited centers like Sourasky and Assuta provide English summaries upon request. Patients have a legal right to receive translated clinical abstracts for international insurance or continued care.
Bookimed Expert Insight: While public hospitals handle massive volumes, with Sourasky seeing over 400,000 patients annually, private facilities provide a smoother experience for non-Hebrew speakers. Data shows that larger centers like Rambam or Sourasky have the infrastructure for international patients. However, choosing a private clinic often ensures faster access to bilingual staff and pre-translated discharge paperwork.
Patient Consensus: Patients note that while intake forms are often Hebrew-primary, doctors and nurses easily switch to English. They recommend using translation apps for digital portals but emphasize that medical staff verbally explain procedures clearly.
Chronic pain aftercare involves transitioning from Israeli clinical supervision to a home-based multidisciplinary plan. This process includes local medical checkups, physical therapy, and remote consultations with Israeli specialists. Patients receive detailed discharge summaries and imaging results to ensure a smooth handover to their local healthcare providers.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center (Ichilov) and Rambam Medical Center serve over 1,000,000 patients combined annually. This high volume means their documentation follows strict international standards. A key advantage of large JCI-accredited facilities is the integration of electronic health records (EHRs). This technology simplifies the transfer of complex pain management protocols to your local physician.
Patient Consensus: Patients note it is important to pre-arrange a local GP before traveling. They recommend getting all imaging in universal formats to avoid reading issues with local radiology centers.